bioRxivNeurosciencePreprint
Sema3A Facilitates a Retrograde Death Signal via CRMP4-Dynein Complex Formation in ALS Motor Axons
Roy MaimoniD, Lior Ankol, Romana WeissováiD, Elizabeth M.H. TankiD, Tal Gradus Pery, Yarden OpatowskyiD, Sami J. BarmadaiD, Martin BalaštíkiD, Eran PerlsoniD
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with selective dysfunction; it causes the death of motor neurons (MNs). In spite of some progress, currently no effective treatment is available for ALS. Before such treatment can be developed, a more thorough understanding of ALS pathogenesis is required. Recently, we demonstrated that ALS-mutated muscles contribute to ALS pathology via secretion of destabilizing factors such as Sema3A; these factors trigger axon degeneration and Neuromuscular Junction (NMJ) disruption. Here, we focus on the molecular mechanism by which muscle contribute to MNs loss in ALS. We identified CRMP4 as part of a retrograde death signal generated in response to muscle-secreted Sema3A, in ALS-diseased MNs. Exposing distal axons to Sema3A induces CRMP4-dynein complex formation and MN loss in both mouse (SOD1G93A) and human-derived (C9orf72) ALS models. Introducing peptides that interfere with CRMP4-dynein interaction in MN axons profoundly reduces Sema3A-dependent MN loss. Thus, we discovered a novel retrograde death signal mechanism underlying MN loss in ALS.\n\nSummaryMaimon et al. identify a novel retrograde death mechanism that contribute to MN loss in ALS, in which CRMP4-Dynein complex is form and retrogradely move along the axon.
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Pablo Martínez, Mónica Silva, … Brigitte van Zundert·Molecular MedicinePeer-reviewed·Oct 25, 2024
- Targeting Neuromuscular Junction Regeneration is a Therapeutic Strategy in ALS
Samuele Negro, Chiara Baggio, … Michela Rigoni·bioRxiv·Jul 13, 2025
- Aldh3a1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to Amyotrophic Lateral Sclerosis progression
Ang Li, Li Dong, … Jingsong Zhou·Free Radical Biology and MedicinePeer-reviewed·Mar 12, 2026
- Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice
Alexandra I. Mot, Ying Li, … Klaus‐Armin Nave·bioRxiv·Jun 11, 2026
- ALS mice carrying pathological mutant TDP-43, but not mutant FUS, display axonal transport defects in vivo
James N. Sleigh, Andrew Paul Tosolini, … Giampietro Schiavo·Cell ReportsPeer-reviewed·Mar 1, 2020
- Early MATR3 loss and distinct neurodegenerative molecular signatures precede the onset of neuropathology in motor neurons and Purkinje cells of MATR3 S85C knock-in mouse model of ALS
Katarina Maksimovic, Majji Rambabu, … Jeehye Park·bioRxiv·Aug 31, 2026